Literature DB >> 33468094

Uganda's increasing dependence on development partner's support for immunization - a five year resource tracking study (2012 - 2016).

Carol Kamya1, Christabel Abewe2, Peter Waiswa3,4, Gilbert Asiimwe5, Faith Namugaya5, Charles Opio5, Immaculate Ampeire6, Stephen Lagony2, Charlotte Muheki2.   

Abstract

BACKGROUND: In Uganda, there are persistent weaknesses in obtaining accurate, reliable and complete data on local and external investments in immunization to guide planning, financing, and resource mobilization. This study aimed to measure and describe the financial envelope for immunization from 2012 to 2016 and analyze expenditures at sub-national level.
METHODS: The Systems of Health Accounts (SHA) 2011 methodology was used to quantify and map the resource envelope for immunization. Data was collected at national and sub-national levels from public and external sources of immunization. Data were coded, categorized and disaggregated by expenditure on immunization activities using the SHA 2011.
RESULTS: Over the five-year period, funding for immunization increased fourfold from US$20.4 million in 2012 to US$ 85.6 million in 2016. The Ugandan government was the main contributor (55%) to immunization resources from 2012 to 2014 however, Gavi, the Vaccine Alliance contributed the majority (59%) of the resources to immunization in 2015 and 2016. Majority (66%) of the funds were managed by the National Medical Stores. Over the five-year period, 80% of the funds allocated to immunization activities were spent on facility based routine immunization (expenditure on human resources and outreaches). At sub-national level, districts allocated 15% of their total annual resources to immunization to support supervision of lower health facilities and distribution of vaccines. Health facilities spent 5.5% of their total annual resources on immunization to support outreaches.
CONCLUSION: Development partner support has aided the improvement of vaccine coverage and increased access to vaccines however, there is an increasing dependence on this support for a critical national program raising sustainability concerns alongside other challenges like being off-budget and unpredictable. To ensure financial sustainability, there is need to operationalize the immunization fund, advocate and mobilize additional resources for immunization from the Government of Uganda and the private sector, increase the reliability of resources for immunization as well as leverage on health financing reforms like the National Health Insurance.

Entities:  

Keywords:  Financial flows; Financing; Gavi; Immunization; Resource tracking; Sustainability; Uganda

Mesh:

Year:  2021        PMID: 33468094      PMCID: PMC7816371          DOI: 10.1186/s12889-021-10178-0

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  15 in total

1.  Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.

Authors:  Judith Kallenberg; Wilson Mok; Robert Newman; Aurélia Nguyen; Theresa Ryckman; Helen Saxenian; Paul Wilson
Journal:  Health Aff (Millwood)       Date:  2016-02       Impact factor: 6.301

2.  Financial sustainability planning for immunization services in Cambodia.

Authors:  Sann Chan Soeung; John Grundy; Jim Maynard; Alan Brooks; Marian Boreland; Duong Sarak; Karl Jenkinson; Beverley-Ann Biggs
Journal:  Health Policy Plan       Date:  2006-05-23       Impact factor: 3.344

3.  Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia.

Authors:  Ulla K Griffiths; Viola S Korczak; Dereje Ayalew; Asnakew Yigzaw
Journal:  Vaccine       Date:  2009-01-13       Impact factor: 3.641

Review 4.  Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?

Authors:  P Lydon; R Levine; M Makinen; L Brenzel; V Mitchell; J B Milstien; L Kamara; S Landry
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

5.  An analysis of how the GAVI alliance and low- and middle-income countries can share costs of new vaccines.

Authors:  Helen Saxenian; Santiago Cornejo; Kira Thorien; Robert Hecht; Nina Schwalbe
Journal:  Health Aff (Millwood)       Date:  2011-06       Impact factor: 6.301

6.  Costs and financing of routine immunization: Approach and selected findings of a multi-country study (EPIC).

Authors:  Logan Brenzel; Darwin Young; Damian G Walker
Journal:  Vaccine       Date:  2015-05-07       Impact factor: 3.641

Review 7.  Financing vaccinations - the South African experience.

Authors:  Mark S Blecher; Filip Meheus; Aparna Kollipara; Robert Hecht; Neil A Cameron; Yogan Pillay; Luisa Hanna
Journal:  Vaccine       Date:  2012-09-07       Impact factor: 3.641

Review 8.  Global support for new vaccine implementation in middle-income countries.

Authors:  Miloud Kaddar; Sarah Schmitt; Marty Makinen; Julie Milstien
Journal:  Vaccine       Date:  2013-04-18       Impact factor: 3.641

9.  Gavi's policy steers country ownership and self-financing of immunization.

Authors:  Klara Henderson; Dimitrios Gouglas; Laura Craw
Journal:  Vaccine       Date:  2016-07-16       Impact factor: 3.641

10.  Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries.

Authors:  Helen Saxenian; Robert Hecht; Miloud Kaddar; Sarah Schmitt; Theresa Ryckman; Santiago Cornejo
Journal:  Health Policy Plan       Date:  2014-02-08       Impact factor: 3.344

View more
  2 in total

1.  Gaps in measles vaccination coverage in Kasese district, Western Uganda: results of a qualitative evaluation.

Authors:  Abel Wilson Walekhwa; David Musoke; Aisha Nalugya; Claire Biribawa; Godfrey Nsereko; Solomon Tsebeni Wafula; Brenda Nakazibwe; Mary Nantongo; Doreen Awino Odera; Achangwa Chiara; Ross Mathew Boyce; Edgar Mugema Mulogo
Journal:  BMC Infect Dis       Date:  2022-07-04       Impact factor: 3.667

Review 2.  Advancing sustainable development goals through immunization: a literature review.

Authors:  Catherine Decouttere; Kim De Boeck; Nico Vandaele
Journal:  Global Health       Date:  2021-08-26       Impact factor: 4.185

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.